BioSpace News Archive

The American Diabetes Association® welcomes the 2022 Principal Officers and Board of Directors.

Milestone Scientific Inc. today reported, that following a successful trial, it has signed an agreement for the purchase of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables with a major Northeast teaching hospital, which is part of one of the leading health systems in the United States.

Timothy B. Niewold Will help lead the nation’s largest staff of Rheumatologists to advance basic and translational research in rheumatic and musculoskeletal diseases.

UpScript Health today announced that it has named George Jones as Chief Operating Officer (COO).

A molecular building block of many animal proteins, the amino acid valine, plays a key role in cancerous growth seen in T cell acute lymphoblastic leukemia, a new study shows.

Dovetail Genomics today announced details of a new study, led by University of Michigan researchers and published in Nature.

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19).

HTG Molecular Diagnostics, Inc., a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel.

Advaxis, Inc., a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, announced that the Company has satisfied the requirements for trading of the Company’s common stock on the OTCQX® Best Market and will begin trading on OTCQX at the open of the market on December 23, 2021 under the symbol ADXS.

Adagene Inc. (“Adagene”) (Nasdaq: ADAG), today announced achievement of a key milestone in its ongoing collaboration with Exelixis for development of novel masked antibody-drug conjugate (ADC) candidates leveraging Adagene’s proprietary SAFEbody precision masking technology.